Drug developed to suppress cancerous tumors also has ability to lower blood sugar levels that were elevated due to obesity and Type 2 diabetes.
Researcher at Harold Hamm Diabetes Center receives $1.6 million NIH grant to better understand how non-alcoholic fatty liver disease (NASH).
OU Health to receive more than $1 million to participate in a National Institutes of Health (NIH) initiative to better understand long-term effects of COVID-19 infection.
Jason Sanders, M.D., MBA, senior vice president and provost of the University of Oklahoma Health Sciences Center, has accepted a position at University of Vermont Health.